A Method to Optimize Mecanical In-exsufflation in Neuromuscular Diseases
- Conditions
- Neuromuscular Disease
- Interventions
- Device: Cough Assist® (JH Emerson Compagny, Cambridge, MA, USA)
- Registration Number
- NCT02137304
- Lead Sponsor
- Centre d'Investigation Clinique et Technologique 805
- Brief Summary
The investigators want to demonstrate that there is an optimal expiratory pressure when using mecanical in-exsufflation for each patient in neuromuscular disease. This compromise is between the need to generate a high pressure difference between alveoli and the mouth and the need to avoide and superior airways collapsus.
- Detailed Description
he investigators want to demonstrate that there is an optimal expiratory pressure when using mecanical in-exsufflation for each patient in neuromuscular disease. This compromise is between the need to generate a high pressure difference between alveoli and the mouth and the need to avoide and superior airways collapsus.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- man or female age18 years
- neuromuscular disease
- coughassist adaptation treatment
- peak cough flow<270liter/minute
- acute organ failure
- insufflation contrindication
- pregnant women/no affiliation to a social security scheme
- plan of legal protection
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description neuromuscular patients Cough Assist® (JH Emerson Compagny, Cambridge, MA, USA) Cough Assist® (JH Emerson Compagny, Cambridge, MA, USA)
- Primary Outcome Measures
Name Time Method optimal negative pressure treshold value 20 minutes Optimal negative pressure treshold value measured for a flow superior or equal to 160 liter/minute and 270 liter/minute
- Secondary Outcome Measures
Name Time Method volume-flow curve aspect 5 minutes optimal pressure treshold based on the best peak flow. 10 minutes
Trial Locations
- Locations (1)
Hôpital R. POINCARE
🇫🇷Garches, France